Effect of Intravitreally Administered AIV007 in Subjects With nAMD
Status:
Recruiting
Trial end date:
2021-09-01
Target enrollment:
Participant gender:
Summary
To determine safety, pharmacokinetics, and duration of effect of intravitreally administered
AIV007 gel suspension in subjects with neovascular age-related macular degeneration